Anti-c3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases

TW202633914APending Publication Date: 2026-08-16BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115117123
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-22
Filing Date
2022-12-21
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073600_001
    Figure TWG2TA001073600_001
  • Figure TWG2TA001073600_002
    Figure TWG2TA001073600_002
  • Figure TWG2TA001073600_003
    Figure TWG2TA001073600_003
Patent Text Reader

Abstract

The present invention relates to antibodies and fragments thereof that target the complement C3. More specifically, anti-C3 antibodies and methods of use for the treatment of various diseases or disorders are disclosed.
Need to check novelty before this filing date? Find Prior Art